Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
abroad, abuse, AC, Accentia, AJCC, Allovectin, Anatomy, Barlow, Bayer, Biomedica, BiovaxID, Breakthrough, broadest, bruce, Bulletin, burn, Carcinomasection, cascade, CEC, certainty, cervical, choice, compliant, conjuction, Corrupt, costly, coupled, deceleration, disorder, distant, DNA, Dublin, dysplasia, Electric, EMEA, enable, enjoined, error, evolving, exploit, exploiting, factual, fared, FavID, Favrille, forward, fraudulent, GCP, Genitope, Georgetown, Geron, GmbH, GMP, headcountprior, Hill, HSBC, illegal, implied, inconvenient, Indenture, infrastructure, Joint, Kelly, knowingly, labor, leicher, licensor, lymph, matter, Medarex, Medicaid, Millennium, MyVax, necessarily, NHL, ninety, NSCLC, Omrix, Onyx, opposition, page, placebo, political, preclude, prescribe, prescribed, prioritization, psychology, readily, recourse, referral, refinancing, refocused, reinitiated, remuneration, Reniale, respiratory, retention, retrospective, revoked, Rochester, satisfactory, saving, Secretary, seeRenal, solicit, sorafenib, specialty, stratified, sunitinib, terrorist, thereof, Therion, told, trader, unacceptable, unanticipated, undesirable, unintended, uninvested, unnecessary, unresolved, Vical, vitespen, willingly
Removed:
accelerated, Acorn, advancement, Alza, analyst, Antwerp, aroplatintm, attended, Babson, Barton, bill, Boston, CambriaTech, CancerVax, chadarevian, chair, conform, Consulenza, Corange, Council, Cyanamid, de, dean, dechaene, declining, Defendant, Deutsche, education, efficiently, eisen, EPA, exit, expend, experimental, family, Finanziara, flexibly, gamil, GEA, Genzyme, Ghent, gleevectm, herndon, immunology, INSEAD, jordan, Lecturer, Lesley, line, London, margaret, McGowan, measurable, MIT, Monsanto, mutual, NearEast, North, organized, OSHA, Pasfin, Pharma, professor, promulgate, reached, reclassified, Regenerative, Repair, Roche, russell, Servizi, Shearman, Sloan, Smith, SpA, Sterling, streamline, Suisse, SurfCast, Syntek, Title, tom, typical, wadih, Whitehead, workload, Zurich
Filing tables
Filing exhibits
- 10-K Annual report
- 10.4 Form of Idemnification Agreement
- 10.5 Sublease
- 10.33 Executive Change of Control Plan
- 10.34 2003 Executive Incentive Plan
- 23 Consent of KPMG LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO and CFO Pursuant to Section 906
Related press release
AGEN similar filings
Filing view
External links
EXHIBIT 10.4
SCHEDULE TO INDEMNIFICATION AGREEMENT
The following is a list of the current directors and executive officers of Antigenics who are party to an Indemnification Agreement, the form of which was filed as Exhibit 10.4 to our registration statement on Form S-1 (File No. 333-91747):
Garo H. Armen, Ph.D.
Pramod K. Srivastava, Ph.D.
Bruce Leicher
Renu Gupta
Noubar Afeyan, Ph.D.
Frank V, AtLee III
Gamil G. de Chadarevian
Tom Dechaene
Margaret Eisen
Wadih Jordan
Mark Kessel
Alastair Wood